PARP1 and cancer: Inhibition of poly-(ADP-ribose) polymerase (PARP), a key enzyme in base excision repair, efficiently kills cancer cells with defective Homologous recombination (HR) in BRCA1/2 deficient cancer, which turned as synthetic lethal due to enhanced DNA damage [34].